ClinicalTrials.Veeva

Menu

Prevelance, Predictors and Outcome of Sepsis Associated Liver Injury (SALI)

A

Assiut University

Status

Not yet enrolling

Conditions

Liver Injuries

Treatments

Device: Antibiotic

Study type

Observational

Funder types

Other

Identifiers

NCT06758908
prevelance ,predictors of SALI

Details and patient eligibility

About

prevelance, predictors and outcome of sepsis associated liver injury (SALI)

Full description

patient with liver disease and sepsis at the same time

Enrollment

100 estimated patients

Sex

All

Ages

15 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of SALI
  • must take liver support

Exclusion criteria

  • SALI
  • Thyroid disease

Trial design

100 participants in 1 patient group

SALI
Treatment:
Device: Antibiotic

Trial contacts and locations

0

Loading...

Central trial contact

Dinal ali hamad dina hamad, specialist; Mahmoud sayed zohry, first mastar

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems